Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

NCT06020807 is registered in ClinicalTrials.gov with Nucleix Ltd. as lead sponsor.

NCT NCT06020807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06020807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
Lead sponsor
Nucleix Ltd.
Phase
Observational
Overall status
Completed
Start date
September 5, 2019
Completion date
January 8, 2020
Enrollment
168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non muscle invasive bladder cancer, non-muscle invasive bladder urothelial carcinoma